Sentiment Trading

DSS, Inc.’s subsidiary, Impact BioMedical Inc., has merged with global pharmaceutical company Dr. Ashleys Limited, creating a new publicly traded entity with enhanced capabilities in the biohealth innovation sector.

DSS Inc is a multifaceted leader in the industrials sector, operating across various sectors and positioning itself for future growth through innovation, sustainability, and strategic market expansion.